1975-2017年美国黑色素瘤过度诊断的流行病学分析
该研究利用1975至2017年监测、流行病学与最终结果计划数据,分析美国白人黑色素瘤发病与死亡趋势以刻画过度诊断。43年间发病与死亡在不同人群亚组呈不一致变化,55-74岁女性趋势最提示单纯过度诊断,其他组提示过度诊断叠加基础风险变化。原位黑色素瘤发病持续上升,过度诊断在美国女性及原位病变中相对更明显。
要点
- 55-74岁女性发病与死亡趋势最提示单纯过度诊断。
- 年轻个体风险下降、老年男性风险上升,提示过度诊断叠加基础风险变化。
- 原位黑色素瘤发病在全人群中持续增加。
核心结论
- 美国白人黑色素瘤发病与死亡在43年间呈不一致变化,过度诊断在美国女性及原位黑色素瘤中相对更明显。
研究设计与样本
- 基于监测、流行病学与最终结果计划1975至2017年数据的流行病学趋势分析,对象为美国白人。
主要发现
- 55-74岁女性发病与死亡趋势最提示单纯过度诊断。
- 其他人群呈混合变化,提示过度诊断叠加基础疾病风险改变,年轻个体风险下降而老年男性风险上升。
- 男性死亡与发病及女性死亡存在队列效应,女性发病队列效应不明显,提示时期效应对女性发病变化影响更大。
- 年轻个体死亡率长期下降,15-44岁个体及45-54岁男性侵袭性发病近期趋于稳定。
- 原位黑色素瘤发病在全人群中持续增加。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The primary cause of the increase in melanoma incidence in the United States has been suggested to be overdiagnosis. We used Surveillance, Epidemiology, and End Result Program data from 1975 to 2017 to examine epidemiologic trends of melanoma incidence and mortality and better characterize overdiagnosis in white Americans. Over the 43-year period, incidence and mortality showed discordant temporal changes across population subgroups; trends most suggestive of overdiagnosis alone were present in females aged 55-74. Other groups showed mixed changes suggestive of overdiagnosis plus changes in underlying disease risk (decreasing risk in younger individuals and increasing risk in older males). Cohort effects were identified for male and female mortality and male incidence but were not as apparent for female incidence, suggesting that period effects have had a greater influence on changes in incidence over time in females. Encouraging trends included long-term declines in mortality in younger individuals and recent stabilization of invasive incidence in individuals aged 15-44 years and males aged 45-54 years. Melanoma in situ incidence, however, has continued to increase throughout the population. Overdiagnosis appears to be relatively greater in American females and for melanoma in situ.
引用
- Kurtansky NR, Dusza SW, Halpern AC, et al. An Epidemiologic Analysis of Melanoma Overdiagnosis in the United States, 1975-2017. J Invest Dermatol. 2021. PMID: 34902365. doi:10.1016/j.jid.2021.12.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。